From Maryland Matters
By Bruce DePuyt
September 11, 2019
EXCERPT
An exchange of letters between the Hogan administration and the Maryland Health Care Commission appears to offer a path to fund and staff the state’s new Prescription Drug Advisory Board — though the lawmakers who pushed for the panel’s creation are not ready to declare victory.
The correspondence comes in the wake of Republican Gov. Lawrence J. Hogan Jr.’s initial refusal to fund the board’s first year of operations — a total of $830,000.
The drug board, which the legislature created earlier this year with bipartisan support, is charged with coming up with ways of forcing down the cost of medications judged to be overly expensive, as a way of providing consumers with relief.
Last modified: September 11, 2019
